中国临床药理学杂志2024，Vol.40Issue(9)：1380-1384,5.DOI:10.13699/j.cnki.1001-6821.2024.09.030
淫羊藿次苷Ⅰ的药理活性研究现状
Research progress in pharmacological activity of Icariside I
摘要
Abstract
Epimedium is a common tonic Chinese herbal medicine,which has the effects of anti-aging,inhibiting tumor and enhancing immune function.Icariside Ⅰ is a trace flavonoid in epimedium,which has many pharmacological activities,such as promoting osteogenic transformation,preventing osteoporosis,resisting tumor,protecting heart and regulating intestinal flora.Icariside Ⅰ,as a natural active ingredient,has lots of advantages compared with many chemical drugs,such as low incidence of adverse drug reactions,wide sources and green safety.This paper aims to summarize the research on pharmacological activities about icariside Ⅰ that published in recent years,and hope to provide reference for the exploitation and application about icariside Ⅰ.关键词
淫羊藿苷/淫羊藿次苷Ⅰ/骨质疏松/肿瘤/药理活性Key words
Icariin/Icariside Ⅰ/osteoporosis/tumor/pharmacological activity分类
中医学引用本文复制引用
张月,刘格歌,陈旺..淫羊藿次苷Ⅰ的药理活性研究现状[J].中国临床药理学杂志,2024,40(9):1380-1384,5.基金项目
陕西省自然科学基础研究计划基金资助项目(2022JM-576) （2022JM-576）
陕西省科技厅重点研发计划基金资助项目(2023-YBNY-15) （2023-YBNY-15）
秦巴生物资源与生态环境重点实验室(培育)"市校共建"科研专项基金资助项目(SXC-2302) （培育）
